TGA investigates possible metformin contamination
But doctors have been urged to continue prescribing the diabetes medication
The TGA is reviewing the safety of all metformin products after the Singaporean regulator recalled three medicines that contained traces of a carcinogen.
The move follows similar investigations by the US and European regulators, amid concerns more metformin products could be contaminated by N-nitrosodimethylamine (NDMA).
